GLIMDA MV1 (Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg))

GLIMDA MV1 is a combination medication that is generally used to help manage blood sugar levels in adults with type 2 diabetes. It supports patients by improving their body’s response to insulin and reducing the amount of sugar produced by the liver. This medicine may be part of a broader diabetes management plan that includes diet and exercise.

The active ingredients in GLIMDA MV1 work together to help control blood sugar levels. Glimepiride stimulates the pancreas to release more insulin, which helps lower blood sugar. Metformin decreases the amount of sugar produced by the liver and improves how the body uses insulin. Voglibose works by slowing down the absorption of carbohydrates from the gut, which helps prevent spikes in blood sugar after meals.

For best results, it is important to store GLIMDA MV1 in a cool, dry place, away from direct sunlight. Consistency in taking this medication as prescribed will support effective management of blood sugar levels. Always be mindful of any general precautions indicated in the package leaflet and discuss with a healthcare provider if you have any concerns.

As with any medication, there may be mild side effects. Some individuals might experience digestive issues such as gas, bloating, or mild stomach upset. Other common effects can include dizziness or headaches.

This is general information, not a substitute for medical advice. Always consult a doctor/pharmacist and read the package leaflet.